Wells Fargo & Company »

Design Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $27k 10k 2.65
2023-09-30 $19k 8.0k 2.36
2023-06-30 $79k 13k 6.30
2022-09-30 $6.8k 406 16.67
2022-06-30 $5.8k 436 13.33
2022-03-31 $10k 653 15.90
2021-12-31 $213k 9.9k 21.42